1. Proton pump inhibitor use and risk of hip fracture in patients with type 2 diabetes
   Ya-Shuan Chou et al, 2020, Sci Rep CrossRef
2. Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo
   Yu-Xi Li et al, 2020, Stem Cells International CrossRef
3. Biomechanical and biochemical evaluation of the effect of systemic application of omeprazole on the osseointegration of titanium implants
   Samet Tekin et al, 2021, Int J Implant Dent CrossRef
4. Влияние омепразола на остеобласты и остеокласты in vivo и в модели in vitro с использованием чешуи рыбы
   M.I. Zanaty et al, 2021, БМ CrossRef
5. Long-term use of proton pump inhibitors adversely affects minerals and vitamin metabolism, bone turnover, bone mass, and bone strength
   Md. Saddam Hussain et al, 2021 CrossRef
6. Proton Pump Inhibitors and the Risk of Early Aseptic Loosening in Hip and Knee Arthroplasty
   Iskandar Tamimi et al, 2022, Geriatr Orthop Surg Rehabil CrossRef
7. Radiodynamic Therapy with Acridine Orange Is an Effective Treatment for Bone Metastases
   Gemma Di Pompo et al, 2022, Biomedicines CrossRef